Comprehensive Tumor Profiling
The Caris Molecular Intelligence® comprehensive tumor profiling approach to assess DNA, RNA and proteins reveals a molecular blueprint to guide more precise and individualized treatment decisions from about 60+ FDA-approved therapies.
Whole Exome Sequencing
(Mutations, Indels & Copy Number Alterations)
Whole Transcriptome Sequencing
(Fusions & Variant Transcripts)
The information below details the biomarkers analyzed by technology for the tumor type submitted. Before ordering testing services, please refer to this profile menu to view the most-up-to date listing of biomarkers that will be performed. Tests may vary if samples with insufficient tissue are submitted.
Next Generation Sequencing (NGS)
Whole Transcriptome Sequencing (WTS)
Select tumor type to see specific tests to be performed.
Caris applies the appropriate tumor-specific customizations standard with every MI Profile test order.